The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2017

Filed:

Dec. 17, 2011
Applicants:

Yang Je Cho, Seoul, KR;

NA Gyong Lee, Seoul, KR;

Jin Wook Jang, Seoul, KR;

Kwang Sung Kim, Gyeonggi-do, KR;

Won Ii Yoo, Seoul, KR;

Inventors:

Yang Je Cho, Seoul, KR;

Na Gyong Lee, Seoul, KR;

Jin Wook Jang, Seoul, KR;

Kwang Sung Kim, Gyeonggi-do, KR;

Won II Yoo, Seoul, KR;

Assignee:

EYEGENE, INC., Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/145 (2006.01); A61K 39/29 (2006.01); A61K 39/04 (2006.01); A61K 39/07 (2006.01); A61K 39/095 (2006.01); A61K 39/21 (2006.01); A61K 39/245 (2006.01); A61K 39/25 (2006.01); A61K 39/102 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/0018 (2013.01); A61K 39/04 (2013.01); A61K 39/07 (2013.01); A61K 39/095 (2013.01); A61K 39/102 (2013.01); A61K 39/145 (2013.01); A61K 39/21 (2013.01); A61K 39/245 (2013.01); A61K 39/25 (2013.01); A61K 39/29 (2013.01); A61K 39/292 (2013.01); A61K 2039/55572 (2013.01); C12N 2710/16634 (2013.01); C12N 2710/16734 (2013.01); C12N 2730/10134 (2013.01); C12N 2740/16034 (2013.01); C12N 2760/16134 (2013.01);
Abstract

The present invention relates to a pharmaceutical vaccine composition comprising: (a) a pathogen-derived antigen selected from the group consisting ofantigen,antigen, HAV (hepatitis A virus) antigen, HBV (hepatitis B virus) antigen, HCV (hepatitis C virus) antigen, HIV (human immunodeficiency virus) antigen, influenza virus antigen, HSV (herpes simplex virus) antigen, Hib (type b) antigen,antigen,antigen,antigen,antigen and Varicella virus antigen; (b) a deacylated non-toxic LOS (lipooligosaccharide); and (c) a pharmaceutically acceptable carrier.


Find Patent Forward Citations

Loading…